JP2012503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503024A5
JP2012503024A5 JP2011528081A JP2011528081A JP2012503024A5 JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5 JP 2011528081 A JP2011528081 A JP 2011528081A JP 2011528081 A JP2011528081 A JP 2011528081A JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5
Authority
JP
Japan
Prior art keywords
peptidomimetic macrocycle
amino acid
peptidomimetic
independently
macrocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011528081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/057927 external-priority patent/WO2010034028A1/en
Publication of JP2012503024A publication Critical patent/JP2012503024A/ja
Publication of JP2012503024A5 publication Critical patent/JP2012503024A5/ja
Withdrawn legal-status Critical Current

Links

JP2011528081A 2008-09-22 2009-09-22 ペプチド模倣大環状分子 Withdrawn JP2012503024A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9917208P 2008-09-22 2008-09-22
US61/099,172 2008-09-22
PCT/US2009/057927 WO2010034028A1 (en) 2008-09-22 2009-09-22 Peptidomimetic marcrocycles

Publications (2)

Publication Number Publication Date
JP2012503024A JP2012503024A (ja) 2012-02-02
JP2012503024A5 true JP2012503024A5 (cg-RX-API-DMAC7.html) 2012-05-24

Family

ID=41581947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011528081A Withdrawn JP2012503024A (ja) 2008-09-22 2009-09-22 ペプチド模倣大環状分子

Country Status (8)

Country Link
US (1) US20120115783A1 (cg-RX-API-DMAC7.html)
EP (1) EP2342214A1 (cg-RX-API-DMAC7.html)
JP (1) JP2012503024A (cg-RX-API-DMAC7.html)
CN (1) CN102197046A (cg-RX-API-DMAC7.html)
AU (1) AU2009294871A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0918833A2 (cg-RX-API-DMAC7.html)
CA (1) CA2737916A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010034028A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0720306A2 (pt) 2006-12-14 2014-02-04 Aileron Therapeutics Inc Sistemas de macrociclização da bis-sufidrila
CA2678941C (en) 2007-02-23 2018-11-27 Aileron Therapeutics, Inc. Triazole macrocycle systems
KR20160061439A (ko) 2007-03-28 2016-05-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
EP2344520B1 (en) * 2008-09-18 2013-11-13 New York University Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices
WO2010034034A1 (en) 2008-09-22 2010-03-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
BRPI0920899A2 (pt) 2008-11-24 2016-04-26 Aileron Therapeutics Inc macrociclos peptidomiméticos com propriedades melhoradas
BRPI1006139A2 (pt) 2009-01-14 2017-05-30 Aileron Therapeutics Inc macrociclos peptidomiméticos
US20130072439A1 (en) 2009-09-22 2013-03-21 Huw M. Nash Peptidomimetic macrocycles
MX355543B (es) 2010-08-13 2018-04-20 Aileron Therapeutics Inc Star Macrociclos peptidomiméticos.
EP2627662B1 (en) 2010-10-13 2015-09-16 Bristol-Myers Squibb Company Methods for preparing macrocycles and macrocycle stabilized peptides
RU2639523C2 (ru) 2011-10-18 2017-12-21 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы и их применение
JP6450191B2 (ja) * 2012-02-15 2019-01-09 エイルロン セラピューティクス,インコーポレイテッド ペプチドミメティック大環状化合物
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
US9604919B2 (en) 2012-11-01 2017-03-28 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
US20140205681A1 (en) 2013-01-19 2014-07-24 New York University HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION
WO2014138429A2 (en) * 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
WO2016049355A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
EP3294318A4 (en) 2015-03-20 2019-04-03 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. Mcl−1のモジュレーターとしてのペプチド模倣大環状分子
EP4023295A1 (en) 2020-12-29 2022-07-06 IDP Discovery Pharma, S.L. Vegf-regulating peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2830063C (en) * 2003-11-05 2017-10-31 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
US8143228B2 (en) * 2004-07-12 2012-03-27 Medical Research Fund Of Tel Aviv Sourasky Medical Center Agents capable of downregulating an MSF-A dependent HIF-1α and use thereof in cancer treatment
JP2010505831A (ja) * 2006-10-05 2010-02-25 ニューヨーク ブラッド センター, インコーポレイテッド 安定化した、治療用の小型のヘリックス性抗ウイルスペプチド
BRPI0720306A2 (pt) * 2006-12-14 2014-02-04 Aileron Therapeutics Inc Sistemas de macrociclização da bis-sufidrila
CA2678941C (en) * 2007-02-23 2018-11-27 Aileron Therapeutics, Inc. Triazole macrocycle systems

Similar Documents

Publication Publication Date Title
JP2012503024A5 (cg-RX-API-DMAC7.html)
JP2013505300A5 (cg-RX-API-DMAC7.html)
JP2012510430A5 (cg-RX-API-DMAC7.html)
JP2012515172A5 (cg-RX-API-DMAC7.html)
JP2013535514A5 (cg-RX-API-DMAC7.html)
JP2015110654A5 (cg-RX-API-DMAC7.html)
JP2022095872A5 (cg-RX-API-DMAC7.html)
JP2016199546A5 (cg-RX-API-DMAC7.html)
CN101835801B (zh) 转铁蛋白变体和偶联物
RU2017145921A (ru) Пептидомиметические макроциклы
JP2014530868A5 (cg-RX-API-DMAC7.html)
JP2017528444A5 (cg-RX-API-DMAC7.html)
JP2019521139A5 (cg-RX-API-DMAC7.html)
JP6297969B2 (ja) 部位特異的モノpeg化エキセンジン類似体およびその調製方法
TW202332683A (zh) 介白素-23受體之肽抑制劑
JP2015522576A5 (cg-RX-API-DMAC7.html)
DE69130071T2 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
JP2015508777A5 (cg-RX-API-DMAC7.html)
JP2011511076A5 (cg-RX-API-DMAC7.html)
TW201209062A (en) Amide based glucagon superfamily peptide prodrugs
JP2019043957A5 (cg-RX-API-DMAC7.html)
JP2018515101A5 (cg-RX-API-DMAC7.html)
DE602005021858D1 (de) Peptide der amylin familie, verfahren zu deren herstellung und verwendung
JP2013520986A5 (cg-RX-API-DMAC7.html)
CN1133047A (zh) 治疗用肽衍生物